Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Vitamin D levels (25-OH-Vitamin D) were lower (33.8 nmol/L vs 43.6 nmol/L, p=0.0001) in the group of children with overweight/obesity children.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This retrospective review analyzed medical records of children aged 14 years or younger diagnosed with T1D from 2017 to 2022.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prevalence and characteristics of overweight/obesity in children newly diagnosed with type 1 diabetes in Kuwait

Study design awaiting verification · Frontiers in Endocrinology · 2026

Original publication title

Prevalence and characteristics of overweight/obesity in children newly diagnosed with type 1 diabetes in Kuwait

Dalia Al-Abdulrazzaq; Maira Alsaeed; Fatima Al-Ghadban; Aisha Alsaqabi; Doaa Elharifa; Abeer Samir; Hessa Al-Kandari

Copyright © 2026 Al-Abdulrazzaq, Alsaeed, Al-Ghadban, Alsaqabi, Elharifa, Samir and Al-Kandari.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Overweight/obesity influence the presentation of type 1 diabetes in children, highlighting the need for early screening and targeted prevention. Longitudinal follow-up with genetic integration is warranted to better understand their relationship with disease progression and metabolic risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The coexistence of overweight/obesity and type 1 diabetes (T1D) may increase disease burden and management complexity. We assessed the prevalence of overweight/obesity in children newly diagnosed with T1D in Kuwait and characterized their baseline clinical, metabolic, and immunological features.

Source: Introduction

Abstract: What methods does the paper describe?

This retrospective review analyzed medical records of children aged 14 years or younger diagnosed with T1D from 2017 to 2022. Data were obtained from the Childhood-Onset Diabetes electronic Registry (CODeR). Overweight/obesity was defined using WHO growth standards, and T1D diagnosis was confirmed based on the 2018 ISPAD guidelines.

Source: Materials and methods

Abstract: Results

From 2,066 children with T1D in CODeR, 1,265 had BMI data and were included in the present study. Of these, 29.9% (378 children) were overweight/obese at diagnosis. Males were more likely to be overweight/obese than females (55.3% vs. 44.9%, p=0.001). Overweight/obese children were older at diagnosis compared to non-obese children (median age 9.3 vs. 7.3 years, respectively, p=0.0001). These children had a milder clinical presentation, with fewer cases of DKA, lower HbA1c, and lower triglycerides at diagnosis. After adjusting for age and gender, higher BMI z-scores were associated with lower HbA1c levels, reduced odds of DKA, and lower odds of celiac autoimmunity.

Source: Results

Abstract: Conclusion

Overweight/obesity influence the presentation of type 1 diabetes in children, highlighting the need for early screening and targeted prevention. Longitudinal follow-up with genetic integration is warranted to better understand their relationship with disease progression and metabolic risk.

Source: Conclusion
Authors’ abstract

Introduction

The coexistence of overweight/obesity and type 1 diabetes (T1D) may increase disease burden and management complexity. We assessed the prevalence of overweight/obesity in children newly diagnosed with T1D in Kuwait and characterized their baseline clinical, metabolic, and immunological features.

Materials and methods

This retrospective review analyzed medical records of children aged 14 years or younger diagnosed with T1D from 2017 to 2022. Data were obtained from the Childhood-Onset Diabetes electronic Registry (CODeR). Overweight/obesity was defined using WHO growth standards, and T1D diagnosis was confirmed based on the 2018 ISPAD guidelines.

Results

From 2,066 children with T1D in CODeR, 1,265 had BMI data and were included in the present study. Of these, 29.9% (378 children) were overweight/obese at diagnosis. Males were more likely to be overweight/obese than females (55.3% vs. 44.9%, p=0.001). Overweight/obese children were older at diagnosis compared to non-obese children (median age 9.3 vs. 7.3 years, respectively, p=0.0001). These children had a milder clinical presentation, with fewer cases of DKA, lower HbA1c, and lower triglycerides at diagnosis. After adjusting for age and gender, higher BMI z-scores were associated with lower HbA1c levels, reduced odds of DKA, and lower odds of celiac autoimmunity.

Conclusion

Overweight/obesity influence the presentation of type 1 diabetes in children, highlighting the need for early screening and targeted prevention. Longitudinal follow-up with genetic integration is warranted to better understand their relationship with disease progression and metabolic risk.

Publication and source details

Original title: Prevalence and characteristics of overweight/obesity in children newly diagnosed with type 1 diabetes in Kuwait

Dalia Al-Abdulrazzaq; Maira Alsaeed; Fatima Al-Ghadban; Aisha Alsaqabi; Doaa Elharifa; Abeer Samir; Hessa Al-Kandari

Frontiers in Endocrinology · 2026

* Correspondence: Dalia Al-Abdulrazzaq, dalia.alabdulrazzaq@ku.edu.kw
†

ORCID: Dalia Al-Abdulrazzaq, orcid.org/0000-0002-4613-865X

Copyright © 2026 Al-Abdulrazzaq, Alsaeed, Al-Ghadban, Alsaqabi, Elharifa, Samir and Al-Kandari.2026Al-Abdulrazzaq, Alsaeed, Al-Ghadban, Alsaqabi, Elharifa, Samir and Al-Kandarihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This project is funded by the Dasman Diabetes Institute [RA 2011-006].

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:31:13.357843+00:00

DOI: 10.3389/fendo.2026.1769706 · PMC13082977